A detailed history of Koshinski Asset Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 33,393 shares of BMY stock, worth $1.39 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
33,393
Previous 41,048 18.65%
Holding current value
$1.39 Million
Previous $2.11 Million 14.06%
% of portfolio
0.19%
Previous 0.33%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $367,286 - $416,432
-7,655 Reduced 18.65%
33,393 $1.81 Million
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $230,958 - $275,597
4,764 Added 13.13%
41,048 $2.11 Million
Q3 2023

Oct 18, 2023

SELL
$57.89 - $64.73 $41,507 - $46,411
-717 Reduced 1.94%
36,284 $2.11 Million
Q2 2023

Jul 28, 2023

SELL
$63.71 - $70.74 $809,562 - $898,893
-12,707 Reduced 25.56%
37,001 $2.37 Million
Q1 2023

Apr 12, 2023

BUY
$65.71 - $74.53 $359,499 - $407,753
5,471 Added 12.37%
49,708 $3.45 Million
Q4 2022

Jan 24, 2023

BUY
$68.48 - $81.09 $200,646 - $237,593
2,930 Added 7.09%
44,237 $0
Q3 2022

Oct 18, 2022

BUY
$0.13 - $76.84 $113 - $66,850
870 Added 2.15%
41,307 $2.94 Million
Q2 2022

Jul 12, 2022

BUY
$72.62 - $79.98 $114,231 - $125,808
1,573 Added 4.05%
40,437 $3.11 Million
Q1 2022

Apr 20, 2022

BUY
$61.48 - $73.72 $4,488 - $5,381
73 Added 0.19%
38,864 $2.84 Billion
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $224,924 - $262,208
4,194 Added 12.12%
38,791 $2.42 Billion
Q3 2021

Oct 12, 2021

BUY
$59.17 - $69.31 $941,335 - $1.1 Million
15,909 Added 85.13%
34,597 $2.05 Million
Q2 2021

Jul 26, 2021

SELL
$61.91 - $67.42 $442,470 - $481,850
-7,147 Reduced 27.66%
18,688 $1.25 Million
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $1.25 Million - $1.4 Million
-21,037 Reduced 44.88%
25,835 $1.63 Million
Q4 2020

Mar 30, 2021

BUY
$57.74 - $65.43 $1.74 Million - $1.97 Million
30,073 Added 179.02%
46,872 $2.91 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $969,974 - $1.1 Million
16,799 New
16,799 $2.91 Million
Q4 2020

Feb 02, 2021

SELL
$57.74 - $65.43 $971,648 - $1.1 Million
-16,828 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $429,748 - $476,218
7,483 Added 80.07%
16,828 $1.04 Million
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $158,539 - $185,348
2,892 Added 44.82%
9,345 $549,000
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $26,308 - $38,232
567 Added 9.63%
6,453 $360,000
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $289,650 - $377,822
5,886 New
5,886 $375,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $490,138 - $584,429
-10,863 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $268,228 - $347,828
-5,501 Reduced 33.62%
10,863 $565,000
Q3 2018

Nov 15, 2018

BUY
$55.19 - $62.25 $451,178 - $508,893
8,175 Added 99.83%
16,364 $1.02 Million
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $147,446 - $183,775
-2,918 Reduced 26.27%
8,189 $1.05 Million
Q1 2018

Apr 09, 2018

SELL
$59.92 - $68.98 $107,196 - $123,405
-1,789 Reduced 13.87%
11,107 $702,000
Q4 2017

Jan 17, 2018

BUY
$59.94 - $65.35 $216,503 - $236,044
3,612 Added 38.91%
12,896 $790,000
Q3 2017

Oct 12, 2017

BUY
$55.23 - $63.74 $22,920 - $26,452
415 Added 4.68%
9,284 $0
Q2 2017

Jan 17, 2018

BUY
N/A
2,820 Added 46.62%
8,869 $494,000
Q1 2017

Jan 17, 2018

BUY
N/A
840 Added 16.13%
6,049 $329,000
Q4 2016

Jan 17, 2018

SELL
N/A
-3,148 Reduced 37.67%
5,209 $304,000
Q3 2016

Jan 17, 2018

SELL
N/A
-1,922 Reduced 18.7%
8,357 $451,000
Q2 2016

Jan 17, 2018

BUY
N/A
72 Added 0.71%
10,279 $756,000
Q1 2016

Jan 17, 2018

SELL
N/A
-322 Reduced 3.06%
10,207 $652,000
Q4 2015

Jan 17, 2018

SELL
N/A
-246 Reduced 2.28%
10,529 $724,000
Q3 2015

Jan 17, 2018

SELL
N/A
-264 Reduced 2.39%
10,775 $717,000
Q2 2015

Jan 17, 2018

SELL
N/A
-6,726 Reduced 37.86%
11,039 $735,000
Q4 2014

Jan 17, 2018

BUY
N/A
17,765
17,765 $1.05 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.